Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors.
Cognitive dysfunction in Alzheimer's disease results from a complex interplay of various pathological processes, including the dysregulation of key enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidase B (MAO-B). This study proposes and designs a seri...
Saved in:
Main Authors: | Fatima Zahra Guerguer, Bouchra Rossafi, Oussama Abchir, Yasir S Raouf, Dhabya Bakhit Albalushi, Abdelouahid Samadi, Samir Chtita |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0317261 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
by: El Mehdi Karim, et al.
Published: (2025-03-01) -
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
by: Fatima Zahra Guerguer, et al.
Published: (2025-01-01) -
Moroccan natural products for multitarget-based treatment of Alzheimer’s disease: A computational study
by: Fatima Zahra Guerguer, et al.
Published: (2025-01-01) -
The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
by: Ping-Ho Chen, et al.
Published: (2014-01-01)